相关实验视频

Updated: Jan 10, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

开发一种先进的lentiviral基因疗法用于β-thalassemia的开发

Hongwei Liu¹, Yingying Wang², Rui Zhang²

¹School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610054, China.

Biochemical and biophysical research communications

|November 20, 2025

概括

一种新型的lentiviral vector (LV) 在治疗β-thalassemia方面表现有前途. 这种基因治疗方法成功恢复了小鼠模型中的β-环球蛋白表达和改善了血液健康,提供了潜在的治疗方法.

科学领域:

血液学血液学血液学
基因治疗基因治疗
分子生物学分子生物学

背景情况:

β-thalassemia是一种遗传性血液疾病.
病毒载体 (LV) 介导的基因疗法提供了潜在的治疗方法.
优化LV用于造血干细胞 (HSC) 基因疗法至关重要.

研究的目的:

为beta-thalassemia基因疗法构建和评估红细胞特异性LVs.
为了识别具有最佳病毒标位和β-环球蛋白表达的LV.
为了评估LV的治疗疗效在贝塔血病小鼠模型中.

主要方法:

构建和体外评价5个红状腺特异性LVs.
鼠标HSCs的转导与HS40 LV的领先.
将修改后的HSC移植到beta-thalassemia小鼠中.
血液学指数和组织病理学指数的评估.

主要成果:

所有的LV在体外表达了β-环球蛋白.
新型HS40 LV表现出优越的病毒标位和表达.
在小鼠中,HS40 LV基因治疗导致血红蛋白水平的改善和疾病病理的减少.
较高的调节剂量增强了植入和治疗效果.

结论:

新型HS40 LV在小鼠模型中有效改善β-血症.
HS40 LV基因疗法对β-thalassemia具有显著的治疗潜力.
这种LV是临床转化的一个有希望的候选人.

关键词:

红状腺体的监管要素基因治疗是一种基因疗法.Hbb(th3/+) 鼠标模型模型这是一个lentiviral向量.在β-thalassemia中,

更多相关视频

Lentiviral Mediated Delivery of shRNAs to hESCs and NPCs Using Low-cost Cationic Polymer Polyethylenimine PEI

Lentiviral Mediated Delivery of shRNAs to hESCs and NPCs Using Low-cost Cationic Polymer Polyethylenimine PEI

Published on: May 24, 2022

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on: October 3, 2019

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.